Biodefense startup Valthos raises $30 million in funding, with participation from OpenAI
ChainCatcher news, biotechnology defense startup Valthos has raised $30 million in funding from the OpenAI Startup Fund, Lux Capital, and Founders Fund.
The company's AI system can update medical countermeasures according to the changing speed of biological threats, enabling researchers and government agencies to identify and respond to pathogens as quickly as possible. Valthos was founded in New York last November, and its leadership includes: former Palantir Technologies Head of Life Sciences Kathleen McMahon, former Oxford University computational neuroscience researcher Tess van Stekelenburg, and founding AI engineer Victor Mao (who previously served as a research engineer at Google DeepMind).
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Decentralized RWA infrastructure project Infinite Galaxy Protocol officially launches Genesis Node sale
HyperLiquid co-founder: No external fundraising has been conducted, so there are no investor HYPE token unlocks
Santiment: Stablecoin yields decline, Ethereum may soon return to the $3,200 level
Data: Ethereum staking rate reaches 28.65%, Lido market share at 24.12%
